Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

NCT02860130 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT02860130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02860130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
Lead sponsor
Vantive Health LLC
Phase
Phase 3
Overall status
Terminated
Start date
September 27, 2016
Completion date
May 12, 2018
Enrollment
34 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, continuous renal replacement therapy (crrt), regional citrate anticoagulation (rca)